1 – 10 of 439
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Breast cancer in young women. Aspects of heredity and contralateral disease.
-
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
Dahlgren, Malin LU ; George, Anthony LU ; Brueffer, Christian LU
; Gladchuk, Sergii
LU
; Chen, Yilun
LU
; Vallon-Christersson, Johan
LU
; Hegardt, Cecilia
LU
; Häkkinen, Jari
LU
; Ryden, Lisa
LU
and Malmberg, Martin
LU
, et al.
(2021)
In JNCI Cancer Spectrum
5(2).
Mark
- Body constitution, statin use, and tumor characteristics. Implications for prognosis.
-
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
Berger, Karoline ; Rhost, Sara ; Rafnsdóttir, Svanheiður ; Hughes, Éamon ; Magnusson, Ylva ; Ekholm, Maria LU ; Stål, Olle ; Rydén, Lisa LU
and Landberg, Göran
LU
(2021)
In BMC Cancer
21(1).
Mark
-
RNA Sequencing for Molecular Diagnostics in Breast Cancer
Brueffer, Christian LU
(2021)
In Lund University, Faculty of Medicine Doctoral Dissertation Series
Mark
- Obesity, Adipocytes and Breast Cancer – Insights from Translational Studies
- Drug use disorder and risk of incident and fatal breast cancer : a nationwide epidemiological study
-
Association between breast cancer risk and disease aggressiveness : Characterizing underlying gene expression patterns
Ugalde-Morales, Emilio ; Grassmann, Felix ; Humphreys, Keith LU ; Li, Jingmei ; Eriksson, Mikael ; Tobin, Nicholas P. LU ; Borg, Åke LU ; Vallon-Christersson, Johan LU
; Hall, Per
and Czene, Kamila
(2021)
In International Journal of Cancer
148(4).
p.884-894
Mark
- Regulatory interplay between mir-181a-5p and estrogen receptor signaling cascade in breast cancer
- Endocrine disrupting chemicals and breast cancer : a systematic review of epidemiological studies